Cargando…
Mechanisms of confluence-dependent expression of CD26 in colon cancer cell lines
BACKGROUND: CD26 (dipeptidyl peptidase IV, DPPIV) is a 110 kDa surface glycoprotein expressed in most normal tissues, and is a potential novel therapeutic target for selected cancers. Our work evaluates the mechanism involved in confluence-dependent CD26 expression in colon cancer. METHODS: Colon ad...
Autores principales: | Abe, Masako, Havre, Pamela A, Urasaki, Yasuyo, Ohnuma, Kei, Morimoto, Chikao, Dang, Long H, Dang, Nam H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038146/ https://www.ncbi.nlm.nih.gov/pubmed/21284881 http://dx.doi.org/10.1186/1471-2407-11-51 |
Ejemplares similares
-
CD26 Expression on T-Anaplastic Large Cell Lymphoma (ALCL) Line Karpas 299 is associated with increased expression of Versican and MT1-MMP and enhanced adhesion
por: Havre, Pamela A, et al.
Publicado: (2013) -
CD26 expression on T cell lines increases SDF-1-α-mediated invasion
por: Havre, P A, et al.
Publicado: (2009) -
CD26/Dipeptidyl Peptidase IV and Its Multiple Biological Functions
por: Pan, Kelsey, et al.
Publicado: (2021) -
Current and Emerging Therapy for Malignant Pleural Mesothelioma: Focus on CD26/Dipeptidyl Peptidase IV as a Therapeutic Target
por: Doonan, Bently P., et al.
Publicado: (2017) -
CD9 Negatively Regulates CD26 Expression and Inhibits CD26-Mediated Enhancement of Invasive Potential of Malignant Mesothelioma Cells
por: Okamoto, Toshihiro, et al.
Publicado: (2014)